P-Menth-1-en-9-yl acetate
Common Name: |
P-Menth-1-en-9-yl acetate |
IUPAC Name: |
2-(4-methylcyclohex-3-en-1-yl)propyl acetate |
Molecular Formula: |
C5H10OS |
SMILES: |
CC1=CCC(CC1)C(C)COC(=O)C |
Inchi: |
1S/C12H20O2/c1-9-4-6-12(7-5-9)10(2)8-14-11(3)13/h4,10,12H,5-8H2,1-3H3 |
Inchi Key: |
QUHIXSUMNSRNNP-UHFFFAOYSA-N |
Cas No: |
28839-13-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
118.20 |
Mass (g/mol) |
196.146 |
Molar Refractivity |
34.28 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
55.87 |
Hetero Atoms |
2 |
Heavy Atoms |
7 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
228.00 to 232.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.027 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
2.932 |
iLOGP |
1.51 |
XLOGP3 |
0.60 |
WLOGP |
1.28 |
MLOGP |
1.01 |
ESOL Log S |
-0.82 |
ESOL Solubility (mg/ml) |
17.9 |
ESOL Solubility (mol/l) |
0.152 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.35 |
Ali Solubility (mg/ml) |
5.32 |
Ali Solubility (mol/l) |
0.05 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.11 |
Silicos-IT Solubility (mg/ml) |
9.07 |
Silicos-IT Solubility (mol/l) |
0.08 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.60 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.52 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.855 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |